Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
5-((t-Butyldimethylsilyl)oxy)-2-ethoxyphenol is an intermediate in synthesizing rac 5’-Hydroxy Reboxetine Hydrochloride (H953470), which is an hydroxylated metabolite of Reboxetine (R142000), a selective noradrenaline reuptake inhibitor and an antidepressant.